| Adverse effect |
Odds ratio; 95% CI; heterogeneity; N of studies, N of participants |
P value |
| Abdominal pain |
OR 0.58, 95% CI 0.31 to 1.07; 1 study, 190 participants |
P = 0.08 |
| Appetite increase |
OR 0.73, 95% CI 0.37 to 1.43; 1 study, 190 participants |
P = 0.36 |
| Diarrhoea |
OR 1.84, 95% CI 0.78 to 4.37; 1 study, 190 participants |
P = 0.17 |
| Dry mouth/excessive thirst |
OR 0.34, 95% CI 0.17 to 0.65; 1 study, 190 participants |
P = 0.001 |
| Nasal congestion |
OR 1.36, 95% CI 0.70 to 2.64; 1 study, 190 participants |
P = 0.36 |
| Enuresis |
OR 1.00, 95% CI 0.49 to 2.04; 1 study, 190 participants |
P = 1.00 |
| Fever |
OR 1.68, 95% CI 0.54 to 5.22; 1 study, 190 participants |
P = 0.37 |
| Frequent urination |
OR 0.45, 95% CI 0.22 to 0.93; 1 study, 190 participants |
P = 0.03 |
| Nausea |
OR 0.60, 95% CI 0.32 to 1.13; 1 study, 190 participants |
P = 0.11 |
| Rash |
OR 2.54, 95% CI 0.87 to 7.43; 1 study, 190 participants |
P = 0.09 |
| Sedation |
OR 1.59, 95% CI 0.84 to 3.00; 1 study, 190 participants |
P = 0.15 |
| Vomiting |
OR 0.49, 95% CI 0.22 to 1.11; 1 study, 190 participants |
P = 0.09 |
| Weight gain |
OR 1.35, 95% CI 0.73 to 2.49; 1 study, 190 participants |
P = 0.33 |
| Weight loss |
OR 1.19, 95% CI 0.63 to 2.26; 1 study, 190 participants |
P = 0.60 |
